HMGB1 and melanoma: To determine whether HMGB1 release is relevant in melanoma patients treated with IL PV-10, we compared the level of HMGB1 in the serum of patients obtained before and after treatment with IL PV-10 (see “Materials and Methods” and Supplementary Figure S1).